Your TL;DR: HHS has begun encouraging applicants to consider the Make Our Children Healthy Again (MAHA) Strategy and the White House research and development budget priorities when structuring proposals. Most applicants will treat this as optional boilerplate. A closer look suggests it may be an early signal about how agencies want researchers, innovators, and small businesses to frame relevance, impact, and public benefit in future funding competitions.
For years, applicants pursuing HHS funding have focused primarily on aligning with the mission of a specific agency, institute, or center. NIH applicants studied institute priorities. CDC applicants focused on public health outcomes. HRSA applicants concentrated on healthcare delivery and access. The process was generally straightforward: understand the funding announcement, understand the agency mission, and build your proposal accordingly.
The latest HHS SBIR/STTR solicitation language introduces something different.
Applicants and recipients are now encouraged to refer to both the Make Our Children Healthy Again (MAHA) Strategy and the OMB-OSTP Research and Development Budget Priorities Memo when structuring applications. On the surface, the language appears harmless. It is not a requirement, a review criterion, or a new compliance obligation. Yet agencies rarely direct applicants toward White House policy documents without a reason.
Organizations preparing proposals over the next several funding cycles may benefit from examining whether their current framing reflects the broader priorities agencies are increasingly being asked to advance.
This Is Not a new requirement; it is a New Signal
Many applicants will immediately ask whether they need to add a paragraph about MAHA to remain competitive.
The answer is almost certainly no.
Reviewers are unlikely to reward applicants for inserting policy language that has little connection to the proposed work. Forced alignment tends to be easy to spot. A pediatric health project that advances childhood wellness naturally connects to MAHA. A project involving advanced manufacturing, cybersecurity, or laboratory instrumentation may require a very different discussion, if any discussion at all.
The more important question is why HHS chose to place this language in the solicitation now. Federal agencies operate within broader policy frameworks established by Congress, the White House, and agency leadership. When those frameworks begin appearing directly in applicant guidance, they often provide an early indication of where future emphasis, funding attention, and program development may be headed.
The Gap Between What Applicants Read and What Agencies Are Signaling
Many applicants view funding announcements as collections of rules. Experienced applicants understand that solicitations also contain clues. That distinction matters here. The risk is not that applicants will fail to mention MAHA. The risk is that they will continue presenting projects as isolated technical achievements without demonstrating how those projects advance larger public priorities.
Reviewers evaluate scientific merit, technical feasibility, and commercialization potential. Agency leadership evaluates portfolios, public impact, strategic relevance, and alignment with broader government objectives. Those perspectives increasingly overlap, particularly when budgets become constrained, and agencies must justify funding decisions against national priorities.
Projects that can clearly articulate their contribution to public health outcomes, disease prevention, healthcare efficiency, domestic competitiveness, or long-term societal benefit may find themselves speaking the same language that agencies are now being encouraged to use internally.
The OMB-OSTP Memo May Be the Bigger Story
Most attention will likely focus on MAHA because it is the more visible and politically recognizable initiative. The budget priorities memo may ultimately prove more consequential.
OMB and OSTP budget guidance help shape agency planning long before applicants see the results in future funding opportunities. These documents influence how agencies think about research investments, emerging technologies, national capabilities, workforce needs, and long-term strategic objectives.
When HHS explicitly directs applicants to review both MAHA and federal research priorities, it suggests the agency wants applicants to think beyond narrow project outcomes and toward broader national impact. That does not mean every proposal must become a policy document. It does mean applicants should understand the environment in which funding decisions are being made. Organizations developing proposals this year may find value in evaluating whether their impact statements, significance discussions, and commercialization narratives reflect the larger outcomes agencies are increasingly expected to support.
What Applicants Should Do Next
The strongest response is neither to ignore the language nor to overreact to it. Applicants should review the MAHA Strategy and the OMB-OSTP memo, identify areas of genuine overlap with their work, and strengthen those connections where they already exist. The goal is not to retrofit a project into a policy agenda. The goal is to understand how agency priorities, reviewer expectations, and federal investment strategies may be evolving.
Funding environments change gradually until they change all at once. Solicitation language often provides one of the earliest indicators that a shift is underway. As more agencies incorporate references to administration priorities and federal research strategies, applicants who understand those signals may be better positioned to frame their work in ways that resonate beyond the technical merits of the project itself.
For organizations evaluating upcoming HHS opportunities, the question may no longer be whether a proposal is scientifically strong. The increasingly important question is whether the proposal demonstrates why that science matters within the priorities federal agencies are being asked to advance.